DaVita Q2 FY26 operating income climbs 20.1% to $579 million; revenue rises 4% to $3.55 billion
Reuters2026/08/04 21:58- DaVita Q2 2026 operating income rose 20.1% to $579 million as revenue climbed 4% to $3.55 billion.
- Six-month net income increased 21.9% to $618 million as operating income rose 8.6% to $1.06 billion.
- U.S. dialysis Q2 revenue rose 2.4% to $3.01 billion while treatments increased 2.8% to 7,226,600.
- U.S. dialysis patient service revenue per treatment slipped 0.4% to $415.87; patient care costs per treatment fell 1% to $277.40.
- Integrated kidney care swung to Q2 operating income of $40 million on higher shared savings; plans to roll out expanded HD broadly.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Update: Oracle Shares Jump Pre-Bell After Fiscal Q1 Adjusted Earnings, Revenue Beat; Lifts Fiscal 2027 Guidance
Vistra Prices $1.5 Billion Junior Subordinated Notes Offering
Meta Platforms Insider Sold Shares Worth $3,301,175, According to a Recent SEC Filing
Piper Sandler initiates coverage of the AI chip sector: Nvidia (NVDA.US) and Broadcom (AVGO.US) as "top picks", with the computing power market expected to reach $2.2 trillion by 2030.
Piper Sandler has initiated coverage of the artificial intelligence (AI) chip and semiconductor sector, giving “Overweight” ratings to AMD, Arm, Broadcom, Marvell Technology, and Nvidia, while Intel and Qualcomm received “Neutral” ratings.
Crypto prices
More
